Epidemiology of Helicobacter pylori infection and gastric cancer in Asia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 3, 2010, Pages 479-486

  Fock, Kwong Ming ^a   Ang, Tiing Leong ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Epidemiology; Gastric cancer; H. pylori

Indexed keywords

ASIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; ENVIRONMENTAL FACTOR; HELICOBACTER INFECTION; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INCIDENCE; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; STOMACH ADENOCARCINOMA; ARTICLE; ASIAN; AUSTRALIA; BACTERIUM ADHERENCE; BANGLADESH; CAMELLIA SINENSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHINA; DUODENUM ULCER; EPIDEMIOLOGICAL DATA; GASTRIC HYPOACIDITY; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HONG KONG; INDIA; INDIAN; INFLAMMATION; INTERMEDIATE RISK POPULATION; JAPAN; KOREA; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALAYSIA; MOLECULAR EPIDEMIOLOGY; OUTCOME ASSESSMENT; PATHOGENICITY ISLAND; POPULATION; SINGAPORE; STOMACH ATROPHY; STOMACH CANCER; STOMACH CARCINOGENESIS; TAIWAN; TEA; THAILAND; VIET NAM;

CAGA PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; POLYPHENOL; TRANSCRIPTION FACTOR RUNX3; TUMOR NECROSIS FACTOR ALPHA;

EID: 77649208684     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06188.x     Document Type: Review

References (74)

1. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig. Liver Dis. 2008 40 : 490 496.
2. Wang KJ, Wang RT. Meta-analysis on the epidemiology of Helicobacter pylori infection in China. Zhonghua Liu Xing Bing Xue Za Zhi 2003 24 : 443 446.
3. Inoue M, Sasazuki S, Wakai K et al. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut 2009 58 : 1323 1332.
4. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am. J. Gastroenterol. 1999 94 : 2094 2099.
5. Teh BH, Lin JT, Pan WH et al. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Res. 1994 14 : 1389 1392.
6. Wong BC, Lam SK, Ching CK et al. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group. J. Gastroenterol. Hepatol. 1999 14 : 120 125.
7. Goh KL, Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur. J. Gastroenterol. Hepatol. 2001 13 : 177 183.
8. Schmidt HM, Goh KL, Fock KM et al. Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter 2009 14 : 256 263.
9. Fock KM. Helicobacter pylori infection - current status in Singapore. Ann. Acad. Med. Singapore 1997 26 : 637 641.
10. Yim JY, Kim N, Choi SH et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007 12 : 333 340.
11. Hoang TT, Bengtsson C, Phung DC, Sorberg M, Granstrom M. Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam. Clin. Diagn. Lab. Immunol. 2005 12 : 81 5.
12. Moujaber T, MacIntyre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL. The seroepidemiology of Helicobacter pylori infection in Australia. Int. J. Infect. Dis. 2008 12 : 500 504.
13. Ahmad MM, Rahman M, Rumi K et al. Prevalence of Helicobacter pylori in asymptomatic population - a pilot serological study in Bangladesh. J. Epidemiol. 1997 7 : 251 254.
14. Graham DY, Adam E, Reddy GT et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig. Dis. Sci. 1991 36 : 1084 1088.
15. Deankanob W, Chomvarin C, Hahnvajanawong C et al. Enzyme-linked immunosorbent assay for serodiagnosis of Helicobacter pylori in dyspeptic patients and volunteer blood donors. Southeast Asian J. Trop. Med. Public Health 2006 37 : 958 965.
16. Lin SK, Lambert JR, Nicholson L, Lukito W, Wahlqvist MI. Prevalence of Helicobacter pylori infection in a representative Anglo-Celtic population in urban Melbourne. J. Gastroenterol. Hepatol. 1998 13 : 505 510.
17. Windsor HM, Abioye-Kuteyi EA, Leber JM, Morrow SD, Bulsara MK, Marshall BJ. Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. Med. J. Aust. 2005 182 : 210 213.
18. You WC, Zhang L, Pan KF et al. Helicobacter pylori prevalence and CagA status among children in two counties of China with high and low risks of gastric cancer. Ann. Epidemiol. 2001 11 : 543 546.
19. Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J. Gastroenterol. Hepatol. 2005 20 : 1603 1609.
20. Falush D, Wirth T, Linz B et al. Traces of human migrations in Helicobacter pylori populations. Science 2003 299 : 1582 1585.
21. Moodley Y, Linz B, Yamaoka Y et al. The peopling of the Pacific from a bacterial perspective. Science 2009 323 : 527 530.
22. Chen J, Bu XL, Wang QY, Hu PJ, Chen MH. Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, southern China. Helicobacter 2007 12 : 164 169.
23. Jais M, Barua S. Seroprevalence of anti Helicobacter pylori IgG/IgA in asymptomatic population from Dehli. J. Commun. Dis. 2004 36 : 132 135.
24. Perez-Perez GI, Taylor DN, Bodhidatta L et al. Seroprevalence of Helicobacter pylori infection in Thailand. J. Infect. Dis. 1990 161 : 1237 1241.
25. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J. Dig. Dis. 2007 8 : 179 185.
26. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 2007 117 : 60 9.
27. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404 : 398 402.
28. Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001 21 : 823 829.
29. Palli D, Saieva C, Luzzi I et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastroenterol. 2005 100 : 1941 1948. (Pubitemid 43919385)
30. Furuta T, Shirai N, Sugimoto M. Controversy in polymorphisms of interleukin-1beta in gastric cancer risks. J. Gastroenterol. 2004 39 : 501 503.
31. El-Omar EM, Rabkin CS, Gammon MD et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 124 : 1193 1201.
32. Lee WP, Tai DI, Lan KH et al. The -251T allele of the interleukin 8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 2005 11 : 6431 6441.
33. Taguchi A, Ohmiya N, Shirai K et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 2005 14 : 2487 2493.
34. Camargo MC, Mera R, Correa P et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006 15 : 1674 1687.
35. Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 2004 23 : 4198 4208.
36. Kitajima Y, Ohtaka K, Mitsuno M et al. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol. Rep. 2008 19 : 197 202.
37. Chang TL, Ito K, Ko TK et al. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 2010 138 : 255 265.
38. Joossens JV, Hill MJ, Elliott P et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int. J. Epidemiol. 1996 25 : 494 504.
39. Goh KL, Cheah PL, Md N et al. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am. J. Gastroenterol. 2007 102 : 40 5.
40. Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr. Cancer 2005 53 : 1 10.
41. Boehm K, Borrelli F, Ernst E et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane. Database. Syst. Rev. 2009 3 CD005004.
42. La Torre G, Chiaradia G, Gianfagna F et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori 2009 95 : 13 22.
43. Asano K, Kubo M, Yonemoto K et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int. J. Cancer 2008 122 : 909 914.
44. Jung MK, Jeon SW, Cho CM et al. Hyperglycaemia, hypercholesterolemia and the risk for developing gastric dysplasia. Dig. Liver Dis. 2008 40 : 361 365.
45. Ikeda F, Doi Y, Yonemoto K et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009 136 : 1234 1241.
46. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001 49 : 347 353.
47. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001 345 : 784 789.
48. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon, France : IARC Press, 2004.
49. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J. Dig. Dis. 2009 10 : 77 84.
50. Tomb JF, White O, Kerlavage AR et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997 388 : 539 547.
51. Linz B, Balloux F, Moodley Y et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007 445 : 915 918.
52. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Inter. Med. 2008 47 : 1077 1083.
53. McNamara D, El-Omar E. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig. Liver Dis. 2008 40 : 504 509.
54. Fock KM, Dhamodaran S, Teo EK et al. Is H. pylori genotypes significant in Asian patients with gastric cancer and GERD? Gut 2006 55 (Suppl. V A258.
55. Erzin Y, Koksal V, Altun S et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter 2006 11 : 574 580.
56. Chomvarin C, Namwat W, Chaicumpar K et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int. J. Infect. Dis. 2008 12 : 30 6.
57. Ghasemi A, Shirazi MH, Ranjbar R et al. The prevalence of cagA and cagE genes in Helicobacter pylori strains isolated from different patient groups by polymerase chain reaction. Pak. J. Biol. Sci. 2008 11 : 2579 2583.
58. Huang JQ, Zheng GF, Sumanac K et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003 125 : 1636 1644.
59. Nguyen LT, Uchida T, Murukami K et al. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J. Med. Microbiol. 2008 57 : 1445 1453.
60. Azuma T, Yamakawa A, Yamazaki S et al. Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J. Clin. Microbiol. 2004 42 : 2508 2517.
61. Satomi S, Yamakawa A, Matsunaga S et al. Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J. Gastroenterol. 2006 41 : 668 673.
62. Vilaichone RK, Mahachai V, Tumwasorn S et al. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter 2004 9 : 453 459.
63. Guruge JL, Falk PG, Lorenz RG et al. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 1998 95 : 3925 3930.
64. Yamaoka Y, Ojo O, Fujimoto S et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006 55 : 775 781.
65. Fock KM, Dhamodaran S, Mitchell HM et al. Clinical implications of functional status of Helicobacter pylori outer inflammatory protein A gene (OipA) in gastric cancers and peptic ulcer diseases in Asia. Gut 2006 55 (Suppl. 55 A6.
66. Odenbreit S, Till M, Hofreuter D, Faller G, Haas R. Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 1999 31 : 1537 1548.
67. Lu H, Wu JY, Beswick EJ et al. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J. Biol. Chem. 2007 282 : 6242 6254.
68. Ang TL, Fock KM, Dhamodaran S, Teo EK, Tan J. Racial differences in Helicobacter pylori, serum pepsinogen and gastric cancer incidence in an urban Asian population. J. Gastroenterol. Hepatol. 2005 20 : 1603 1609.
69. de Vries R, Klok RM, Brouwers JR, Postma MJ. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health. Vaccine 2009 27 : 846 852.
70. Malfertheiner P, Schultze V, Rosenkranz B et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008 135 : 787 795.
71. Fock KM, Talley N, Moayyedi P et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J. Gastroenterol. Hepatol. 2008 23 : 351 365.
72. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am. J. Gastroenterol. 2008 103 : 510 514.
73. Malfertheiner P, Dent J, Zeijlon L et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programme. Aliment. Pharmacol. Ther. 2002 16 : 1431 1442.
74. Vakil N, Talley NJ, Stolte M et al. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastroesophageal reflux disease in Western patients with non ulcer dyspepsia. Aliment. Pharmacol. Ther. 2006 24 : 55 63.